This study is looking at how well a product called Miro3D Wound Matrix helps heal diabetic foot ulcers (sores on the feet common in people with diabetes) and other chronic lower limb wounds. You would receive either Miro3D Wound Matrix along with standard wound care, or standard wound care alone. Miro3D is a special dressing made from pig liver that helps wounds heal. Researchers want to see if adding Miro3D helps wounds close faster or better than standard care alone. To join, you must be at least 18 years old and have a specific type of diabetic foot ulcer or wound between 1 and 20 square centimeters in size. The study plans to enroll 30 people. The main goal is to see how much the wound area shrinks and how much new tissue forms after 4 weeks.

Study design

This is a randomized controlled trial, meaning participants are assigned by chance to one of two groups. It compares Miro3D Wound Matrix plus standard care to standard care alone, and plans to include 30 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary healing outcomes are measured at 4 weeks after you are assigned to a treatment group.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.